Research project

Can new molecular imaging technology guide prostate cancer surgery?

Operation chamber
Complete removal of malignant tissue during prostate cancer surgery can be challenging, especially in later-stage disease, as it can be difficult to distinguish between cancerous and non-cancerous tissue.
Source: pixabay

The Netherlands Cancer Institute (NKI) announced that it has received funding from the Dutch Cancer Society (KWF Kankerbestrijding) to test whether a novel molecular imaging technology can guide prostate cancer surgery. The project will evaluate the imaging technology’s ability to detect prostate cancer during surgery, with the aim of performing more accurate removal of cancerous tissue.

Prostate cancer is the most common cancer among men in Europe with over 350,000 diagnosed in Europe every year. Complete removal of malignant tissue during prostate cancer surgery can be challenging, especially in later-stage disease, as it can be difficult to distinguish between cancerous and non-cancerous tissue. Accordingly, there is a crucial need for new technologies to help surgeons visualize cancer in real time during an operation to ensure that the cancer has been completely removed.

If this technique is successful, we will be able to guide the urologist in the most optimal way by combining pre-operative staging with per-operative imaging using the same tracer.

Dr Marcel Stokkel

In the joint research project, the Netherlands Cancer Institute, University of Twente and industry partners, Lightpoint Medical and Philips will evaluate a novel molecular imaging technology to image the prostate cancer biomarker Prostate Specific Membrane Antigen (PSMA) during surgery. If successful, the technology will be tested in larger clinical trials with the aim of sparing healthy tissue and reducing recurrence rates in prostate cancer surgery.

Dr Marcel Stokkel, Nuclear Medicine Physician at NKI, commented, “If this technique is successful, we will be able to guide the urologist in the most optimal way by combining pre-operative staging with per-operative imaging using the same tracer. If the resection margins can be assessed with highest accuracy during surgery, we might become able to improve recurrence and survival rates. The collaboration with Lightpoint Medical, Philips and the University of Twente is the most optimal setting to reach this goal and to complete this study.”

“We are delighted to embark on this collaboration with the NKI and Philips. Intraoperative molecular imaging holds enormous potential in prostate cancer surgery. This project will bring the technology a step closer to the patients in need of better treatment options” commented Dr David Tuch, CEO of Lightpoint Medical.


Source: Netherlands Cancer Institute

17.10.2017

Related articles

Intraoperative molecular imaging

Tumor dye makes cancerous lymph nodes glow during surgery

Surgeons at Penn Medicine are using a fluorescent dye that makes cancerous cells glow in hopes of identifying suspicious lymph nodes during head and neck cancer procedures. Led by Jason G. Newman,…

Surgery for early prostate cancer often harmful

A major 20-year study provides further evidence that prostate cancer surgery offers negligible benefits to many men with early-stage disease. In such men, who account for most cases of newly…

A map to the heart

The meaning of heart geometry in surgery

Geometry is often referenced for matters of the heart. Marriage has been described as “two parallel lines,” and others have compared love to an “irrational equation” or as unending as…

Related products

Immunochemistry

Beckman Coulter - phi (Prostate Health Index)

Beckman Coulter, Inc.

Interventional systems - Surgical Flat Panel C-Arm

Hologic - Fluoroscan InSight-FD

Hologic, Inc.

Interventional systems - Surgical Flat Panel C-Arm

INTERMEDICAL - "NEW" RADIUS XP

INTERMEDICAL SRL

Interventional systems - Surgical Flat Panel C-Arm

INTERMEDICAL - "NEW" RADIUS XP with Flat Panel

INTERMEDICAL SRL

MRT Coils

NORAS Uni-Lift Prostate Intervention Device

NORAS MRI products GmbH

Interventional systems - Surgical II-C-Arms

Simad - 500 Compact

SIMAD s.r.l.